The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor pathway inhibitor.
Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...
We believe that the article overemphasized the risk associated with medical radiation exposure, and that such a fear-inducing ...
Once regarded as a symbol for luxury, this low-calorie snack has a bunch of health benefits, including helping you sleep, ...
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...
As a Stage 4 breast cancer survivor, I know the importance of maintaining hope after a diagnosis. I was first diagnosed in ...
With Robert F. Kennedy Jr. as health secretary, what was once a fringe movement now controls the halls of power.
Marleen I. Meyers, MD, emphasizes prioritizing whole foods, particularly fruits and vegetables, over relying on supplements for patients with cancer.
Patients with cancer often lose their hair, leaving their heads exposed to the chill of winter and air conditioning. Seat belts are often abrasive to thinning skin, and homeless individuals need ...
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...
Nearly 260 of Hempfield Area School District’s juniors and seniors participated in a 12-hour, no-sitting Mini-THON Friday, a high school version of the popular Penn State THON fundraiser. This is the ...
Novartis said the U.S. Food and Drug Administration has approved the use of Pluvicto against a certain type of prostate cancer. The drug maker said Friday that the FDA green-lit the use of Pluvicto to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results